Home » Topics » BioWorld Science

BioWorld Science
RSS

Synapton phase III trials concluded

Aug. 30, 1996

Prednisone suppresses acute phase in AD patients

Aug. 30, 1996

Botulinum toxin effective in treating writer's cramp

Aug. 30, 1996

Botulinum toxin effective in reducing upper limb spasticity

Aug. 30, 1996

Roche files for approval of Tasmar

Aug. 30, 1996

Tegretol-XR launched in U.S.

Aug. 30, 1996

Cypress Bioscience/PRP merger imminent

Aug. 30, 1996

Celox Laboratories' ViaStem covered under patent

Aug. 30, 1996

DNX Corporation and BioClin International to merge

Aug. 30, 1996

Medtronic acquires catheter product line

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...